Evidence map›Paper›PMID 38350925›Full record

SynthesisHealth and quality of life outcomes2024

Ignored and undervalued in public health: a systematic review of health state utility values associated with syphilis infection.

Patrick Miao, Fern Terris-Prestholt, Christopher K Fairley, Joseph D Tucker, Virginia Wiseman, Philippe Mayaud, Ying Zhang, Jane Rowley, Sami Gottlieb, Eline L Korenromp and 2 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Health and quality of life outcomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. A head-to-head comparison of health utilities and measurement properties of the EQ-5D-5L and SF-6Dv2 among people living with HIV in China.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  4. Article
  5. A Retrospective Cohort Study onInfection and drug resistance · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Patrick MiaoCentral Clinical School, Monash University, Melbourne, Australia.
Fern Terris-PrestholtDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Christopher K FairleyCentral Clinical School, Monash University, Melbourne, Australia.
Joseph D TuckerFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Virginia WisemanDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Philippe MayaudFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Ying ZhangCentral Clinical School, Monash University, Melbourne, Australia.
Jane RowleyGlobal HIV, Hepatitis and Sexual Transmitted Infections Programme, World Health Organization, Geneva, Switzerland.
Sami GottliebDepartment of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Eline L KorenrompUNAIDS, Geneva, Switzerland.
Caroline G Watts *Kirby Institute, University of New South Wales, Sydney, Australia.
Jason J Ong *Central Clinical School, Monash University, Melbourne, Australia. Jason.ong@monash.edu.
Joint United Nations Programme on HIV/AIDS · CHLondon School of Hygiene & Tropical Medicine · GBMelbourne Sexual Health Centre · AUMonash University · AUWorld Health Organization · CHUniversity of North Carolina at Chapel Hill · USUniversity of Sydney · AU

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundSyphilis is a sexually transmitted infection causing significant global morbidity and mortality. To inform policymaking and economic evaluation studies for syphilis, we summarised utility and disability weights for health states associated with syphilis.

methodsWe conducted a systematic review, searching six databases for economic evaluations and primary valuation studies related to syphilis from January 2000 to February 2022. We extracted health state utility values or disability weights, including identification of how these were derived. The study was registered in the international prospective register of systematic reviews (PROSPERO, CRD42021230035).

findingsOf 3401 studies screened, 22 economic evaluations, two primary studies providing condition-specific measures, and 13 burden of disease studies were included. Fifteen economic evaluations reported outcomes as disability-adjusted life years (DALYs) and seven reported quality-adjusted life years (QALYs). Fourteen of 15 economic evaluations that used DALYS based their values on the original Global Burden of Disease (GBD) study from 1990 (published in 1996). For the seven QALY-related economic evaluations, the methodology varied between studies, with some studies using assumptions and others creating utility weights or converting them from disability weights.

interpretationWe found a limited evidence base for the valuation of health states for syphilis, a lack of transparency for the development of existing health state utility values, and inconsistencies in the application of these values to estimate DALYs and QALYs. Further research is required to expand the evidence base so that policymakers can access accurate and well-informed economic evaluations to allocate resources to address syphilis and implement syphilis programs that are cost-effective.

Indexed as

SyphilisCost-Benefit AnalysisDisability-Adjusted Life YearsHealth StatusHumansPublic HealthQuality-Adjusted Life YearsDisability-adjusted life yearDisability weightHealth economicsHealth state utility valueQuality-adjusted life yearQuality of lifeSyphilisUtility weight

Identifiers

PMID38350925
PMCPMC10863090
OpenAlexW4391778981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.